Search

Your search keyword '"Abramyan, Ara M"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Abramyan, Ara M" Remove constraint Author: "Abramyan, Ara M"
49 results on '"Abramyan, Ara M"'

Search Results

1. Atomistic simulations of the Escherichia coli ribosome provide selection criteria for translationally active substrates.

2. High-potency ligands for DREADD imaging and activation in rodents and monkeys.

9. Incorporation of Multiple β2-Hydroxy Acids into a Protein In VivoUsing an Orthogonal Aminoacyl-tRNA Synthetase

10. Dynamic extracellular vestibule of human SERT:Unveiling druggable potential with high-affinity allosteric inhibitors

13. An ab-initio study of pyrrole and imidazole arylamides

14. Atomistic simulations of the Escherichia coliribosome provide selection criteria for translationally active substrates

18. Author response: Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism

20. A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter

22. Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders

26. Chemogenetic ligands for translational neurotheranostics

30. The action of a negative allosteric modulator at the dopamine D2 receptor is dependent upon sodium ions

32. Structure–Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders

33. The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation

38. Structure–Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders

41. The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.

44. Identification of a putative binding site critical for general anesthetic activation of TRPA1.

46. The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors

47. Incorporation of Multiple β 2 -Hydroxy Acids into a Protein In Vivo Using an Orthogonal Aminoacyl-tRNA Synthetase.

48. The action of a negative allosteric modulator at the dopamine D 2 receptor is dependent upon sodium ions.

49. Computational Prediction and Rationalization, and Experimental Validation of Handedness Induction in Helical Aromatic Oligoamide Foldamers.

Catalog

Books, media, physical & digital resources